Morgenesis is a subsidiary of Orgenesis, and it provides point-of-care services.
Morgenesis has raised $30.0M in total funding. The most recent round was Private Equity. The last funding was announced in November 2022.
Morgenesis's investors include Metalmark Capital.
Morgenesis is headquartered in Germantown, United States.
Morgenesis is a subsidiary of Orgenesis, and it provides point-of-care services.
Morgenesis is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Morgenesis — Funding & Investors." VCBacked, November 7, 2022, https://www.vcbacked.co/company/morgenesis. Accessed August 14, 2026.
VCBacked. (2022). Morgenesis — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/morgenesis
{{cite web |title=Morgenesis — Funding & Investors |url=https://www.vcbacked.co/company/morgenesis |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated